purifi
recombin
spike
protein
studi
effect
stimul
human
peripher
blood
monocyt
macrophag
pbmc
examin
inflammatori
gene
mrna
abund
found
proteintr
pbmc
use
gene
array
identifi
differenti
mrna
abund
gene
function
properti
associ
antivir
inflammatori
respons
confirm
cytokin
mrna
increas
realtim
quantit
q
rtpcr
elisa
analyz
sensit
specif
promin
respons
realtim
qrtpcr
protein
shown
stimul
mrna
accumul
dose
depend
manner
treatment
e
protein
also
titrat
proteinspecif
product
secret
elisa
show
dose
nm
produc
signific
increas
p
compar
mocktreat
control
increas
stimul
concentr
nm
compar
concentr
seen
protein
bind
neutral
monoclon
antibodi
suggest
physiolog
relev
nfb
inhibitor
tpck
ntosyllphenylalanin
chloromethyl
keton
could
suppress
product
secret
respons
protein
pbmc
cell
virusinfect
pbmc
activ
transloc
nfb
shown
occur
rapidli
follow
exposur
pbmc
cell
protein
use
highli
sensit
assay
activ
nuclear
nfb
transcript
factor
result
suggest
releas
secret
protein
could
activ
blood
monocyt
recognit
tolllik
receptor
tlr
ligand
sar
coronaviru
sarscov
epidem
rekindl
interest
coronaviru
interact
host
innat
immun
system
sarscovinduc
diseas
sever
acut
respiratori
distress
syndrom
sar
associ
major
inflammatori
compon
increas
cytokin
chemokin
product
respons
viru
infect
focu
sever
investig
frieman
et
al
peripher
blood
monocyt
macrophag
pbmc
tool
investig
host
respons
mechan
pathogenesi
pbmc
may
becom
activ
encount
sarscov
recruit
neutrophil
monocyt
immun
respond
natur
killer
nk
b
cell
site
shape
earli
adapt
immun
et
al
et
al
pbmc
may
also
carri
viru
site
liver
brain
caus
diseas
persist
time
shao
et
al
cleav
matur
larg
extern
domain
bind
angiotensinconvert
enzym
major
cellular
receptor
found
ciliat
nasotrach
epitheli
cell
lung
alveolar
cell
intestin
enterocyt
found
cell
b
cell
macrophag
spleen
lymphoid
organ
li
et
al
chen
subbarao
virion
uncleav
viral
spike
entri
endocyt
vesicl
fusion
plasma
membran
viral
spike
cleav
cathepsin
l
bosch
et
al
trypsin
cleavag
spike
prior
infect
also
permit
entri
plasma
membran
bosch
et
al
factor
xa
membran
bound
proteas
cleav
sar
protein
function
subunit
allow
viral
entri
du
et
al
trimer
direct
membran
fusion
contain
hydrophob
fusion
peptid
close
nterminu
heptad
repeat
region
follow
transmembran
domain
tmd
put
palmytoyl
cystein
rich
region
carboxytermin
cytoplasm
domain
frieman
et
al
thorp
et
al
region
contain
leucin
zipper
domain
import
oligomer
corver
et
al
luo
et
al
spike
trimer
per
sarscov
virion
beniac
et
al
sought
determin
function
affect
inflammatori
respons
monocyt
macrophag
expos
sarscov
spike
protein
focus
interact
cell
membran
virion
envelop
protein
respons
initi
infect
purifi
recombin
truncat
spike
protein
sarscov
urbani
strain
genbank
access
number
obtain
protein
scienc
corpor
meriden
ct
use
recommend
protein
fulli
glycosyl
partial
trimer
activ
bind
elisa
assay
k
rizzo
protein
scienc
corp
person
commun
purifi
product
contain
endotoxin
unit
eu
per
g
protein
recombin
protein
consist
spike
extracellular
domain
truncat
amino
acid
express
expresssf
insect
cell
recombin
baculoviru
truncat
remov
ctermin
tmd
transmembran
domain
cytoplasm
tail
retain
region
contain
leucin
zipper
domain
import
oligomer
luo
et
al
protein
store
c
stabl
c
one
week
song
et
al
purifi
recombin
sarscov
e
protein
e
protein
obtain
biodefens
emerg
infect
research
resourc
repositori
beiresourc
manassa
va
purifi
e
protein
obtain
bacteri
express
e
protein
contain
ntermin
tag
remov
proteolysi
purifi
nickel
affin
chromatographi
found
purifi
e
protein
endotoxin
activ
remov
contamin
endotoxin
use
detoxigel
endotoxin
remov
column
pierc
biotechnolog
ml
column
settl
resin
load
gml
e
protein
dissolv
pb
eluat
fraction
contain
e
protein
collect
graviti
flow
store
c
peripher
blood
obtain
healthi
volunt
leukocyt
separ
centrifug
ficollpaqu
plu
amersham
bioscienc
collin
pbmc
wash
twice
viabl
cell
brought
final
concentr
ml
monocyt
enrich
adsorpt
onto
cm
cultur
flask
incub
day
c
rpmi
supplement
contain
mm
hepe
mm
sodium
pyruv
nonessenti
amino
acid
autolog
serum
decompl
clarifi
obtain
american
type
cultur
collect
atcc
propag
human
fetal
lung
cell
obtain
virom
minnetonka
mn
cell
grown
minimum
essenti
medium
mem
supplement
vv
fb
invitrogen
infect
perform
moi
incub
c
infecti
viru
quantit
plaqu
assay
cell
collin
grubb
sar
pseudoviru
bear
sarscov
protein
defect
genom
express
luciferas
report
prepar
previous
describ
et
al
brief
cell
cotransfect
psar
encod
sarscov
protein
encod
envdefect
luciferaseexpress
genom
plasmid
obtain
yuxian
new
york
blood
center
new
york
ny
use
fugen
reagent
boeringermannheim
supernat
contain
sar
pseudoviru
harvest
h
posttransfect
use
singl
cycl
infect
assay
sar
pseudoviru
infect
cell
incub
dilut
sar
pseudoviru
h
cell
assay
luciferas
activ
express
rel
light
unit
rlu
use
luciferas
kit
promega
madison
wi
cell
gift
garrick
suni
buffalo
buffalo
ny
cell
gift
new
york
blood
center
new
york
ny
cell
line
propag
dmem
supplement
vv
fb
cell
purchas
invivogen
carlsbad
ca
propag
dmem
supplement
vv
fb
gml
blasticidin
human
monocyt
cell
line
obtain
atcc
cultur
rpmi
supplement
contain
mm
hepe
mm
sodium
pyruv
nonessenti
amino
acid
plu
vv
fb
mm
undifferenti
nonadher
cell
cm
flask
becam
differenti
adher
incub
cultur
h
phorbol
myrist
acet
pma
sigma
final
concentr
nm
sarscov
e
envelop
protein
dilut
rpmi
medium
treat
vitro
pbmc
cultur
cellsflask
simul
viruscel
interact
cultur
wash
twice
rpmi
treat
variou
dose
protein
nm
e
protein
nm
l
rpmi
per
cm
flask
mocktreat
incub
min
ice
min
c
ml
rpmi
supplement
ad
cultur
return
c
h
cytoplasm
rna
extract
cell
experi
aliquot
ml
supernat
medium
collect
h
incub
subsequ
elisa
assay
secret
cytokin
nuclear
cell
fraction
assay
activ
nkb
transcript
factor
section
stimul
tolllik
receptor
cell
perform
use
control
agonist
mycobacteri
lipomannan
lmm
smegmati
invivogen
ugml
elass
et
al
mrna
abund
studi
compar
control
proteintr
pbmc
cultur
gearray
q
seri
human
inflammatori
cytokin
receptor
gene
array
superarray
bioscienc
corpor
bethesda
md
rna
extract
use
trireag
follow
method
cell
lysat
molecular
research
center
inc
cincinnati
oh
store
ethanol
c
g
rna
amplifi
label
creat
cdna
probe
use
ampolabel
lpr
probe
synthesi
kit
superarray
bioscienc
corpor
bethesda
md
bound
probe
detect
chemiluminesc
detect
kit
superarray
bioscienc
corpor
bethesda
md
nfb
pathway
respons
oligo
gearray
dna
microarray
superarray
bioscienc
corpor
includ
total
rna
purifi
use
rneasi
column
accord
manufactur
instruct
qiagen
valencia
ca
crna
probe
prepar
use
rna
truelabelingamp
kit
superarray
bioscienc
corpor
bethesda
md
briefli
h
prehybrid
c
probe
hybrid
overnight
c
wash
sever
low
high
stringenc
wash
bound
probe
react
alkalin
phosphataseconjug
streptavidin
detect
array
cdpstar
chemiluminesc
substrat
chemiluminesc
array
imag
captur
use
cool
fuji
imag
ccd
camera
paramet
select
use
local
background
correct
subtract
normal
gapdh
control
array
gapdh
normal
gave
valu
induc
express
could
compar
allow
comparison
densiti
rel
amount
express
rel
intens
array
spot
analyz
use
gearray
express
analysi
suit
softwar
superarray
bioscienc
corpor
bethesda
md
averag
intens
multipl
spot
individu
gene
array
compil
pair
ttest
normal
intens
p
valu
three
independ
experi
use
gener
list
gene
signific
chang
gene
express
control
proteintr
sampl
reproduc
chang
independ
experi
analyz
qualiti
control
measur
includ
subtract
baselin
set
housekeep
gene
phosphat
dehydrogenas
gapdh
one
array
comparison
analysi
perform
proteintr
sampl
correspond
mocktreat
control
baselin
signal
fold
chang
calcul
signal
ratio
normal
control
signal
valu
activ
analys
elisa
perform
select
gene
confirm
biolog
function
result
express
mean
sd
comparison
valu
test
result
multipl
individu
donor
pbmc
cultur
cell
evalu
student
ttest
pair
sampl
p
valu
wolk
elisa
assay
secret
cytokin
chemokin
pbmc
cultur
treat
protein
e
protein
mock
treat
describ
section
cultur
medium
sampl
variou
time
posttreat
assay
secret
cytokin
elisa
media
sampl
store
c
protein
secret
cultur
medium
quantit
use
highli
specif
sensit
elisa
kit
quantikin
elisa
kit
obtain
r
system
minneapoli
mn
perform
describ
manufactur
sensit
assay
pgml
assay
pgml
assay
pgml
assay
pgml
assay
pgml
secret
cytokin
chemokin
level
compar
base
picogram
per
ml
cultur
medium
quantif
activ
nfb
transcript
factor
nuclear
fraction
treat
mocktreat
pbmc
assay
ezdetect
nfb
transcript
factor
kit
pierc
biotechnolog
rockford
il
method
publish
detail
rosenau
et
al
mocktreat
pbmc
control
pbmc
treat
nm
protein
h
harvest
incub
versen
invitrogen
room
temperatur
min
scrape
cold
pb
adher
cell
cellsflask
similarli
treat
cytoplasm
nuclear
cell
fraction
prepar
use
neper
nuclear
cytoplasm
extract
reagent
pierc
rockford
il
pbmc
nuclear
extract
use
posit
control
pbmc
stimul
ngml
recombin
human
r
system
minneapoli
mn
min
nuclear
extract
prepar
describ
davi
et
al
nuclear
cytoplasm
extract
immedi
place
c
protein
concentr
determin
microbca
protein
assay
pierc
protein
research
product
rockford
il
l
g
nuclear
extract
incub
well
coat
nfb
consensu
sequenc
h
activ
form
nfb
transcript
factor
bind
consensu
sequenc
well
first
incub
well
wash
incub
specif
primari
antibodi
nfb
h
incub
primari
antibodi
well
wash
incub
secondari
hrpconjug
antibodi
h
wash
chemiluminesc
substrat
ad
well
result
signal
detect
use
luminomet
biotek
multifunct
plate
reader
winooski
vt
activ
nfb
transcript
factor
report
luminesc
per
ug
protein
tpck
ntosyllphenylalanin
chloromethyl
keton
sigma
product
st
loui
mo
irrevers
inhibitor
serin
proteas
chymotrypsinlik
specif
prepar
mm
stock
ethanol
store
c
tpck
rpmi
medium
use
nfb
inhibitor
henkel
et
al
tpck
act
inhibit
proteas
proteolyt
degrad
nfb
releas
undergo
nuclear
transloc
henkel
et
al
briefli
treatment
protein
viru
pbmc
cultur
pretreat
tpck
min
ice
stimul
protein
section
viru
section
incub
medium
tpck
h
jovasev
et
al
tpck
effect
viru
product
infect
cell
measur
plaqu
assay
cultur
supernat
qrtpcr
use
quantit
effect
e
protein
cytokin
mrna
abund
rna
vitro
pbmc
cultur
revers
transcrib
cdna
use
revers
transcriptas
kit
promega
promega
inc
madison
wi
rel
abund
mrna
speci
quantit
use
realtim
quantit
pcr
use
specif
primer
primer
synthes
invitrogen
integr
dna
technolog
skoki
il
use
brilliant
sybr
green
qpcr
master
mix
stratagen
stratagen
inc
la
jolla
ca
provid
precis
quantif
initi
target
pcr
reaction
amplif
plot
examin
point
earli
log
phase
product
accumul
accomplish
assign
fluoresc
threshold
background
determin
time
point
sampl
amplif
plot
reach
threshold
defin
threshold
cycl
number
c
threshold
numer
valu
assign
automat
softwar
run
calcul
baselin
c
valu
assign
particular
sampl
thu
reflect
point
amplif
reaction
suffici
number
amplicon
accumul
baselin
suitabl
threshold
select
data
analyz
c
valu
sampl
determin
differ
threshold
cycl
number
c
use
quantifi
rel
amount
pcr
target
contain
within
tube
rel
express
mrna
speci
calcul
use
compar
c
method
briefli
sampl
differ
c
valu
c
calcul
mrna
take
mean
c
duplic
tube
subtract
mean
c
duplic
tube
refer
rna
measur
aliquot
rtreaction
c
treat
sampl
subtract
c
untreat
control
sampl
gener
c
mean
c
measur
use
calcul
express
test
gene
rel
refer
gene
normal
untreat
control
follow
transcript
accumul
index
tai
rel
express
c
calcul
assum
pcr
reaction
work
effici
pcr
effici
found
therefor
assumpt
introduc
minim
error
calcul
investig
effect
treatment
protein
inflammatori
respons
compar
rel
abund
mrna
speci
treat
mocktreat
pbmc
use
microarray
analysi
pair
ttest
use
detect
mrna
speci
statist
signific
differ
express
p
fig
fig
differenti
mrna
abund
determin
microarray
focus
immunolog
relev
gene
treatment
pbmc
cell
nm
protein
h
statist
signific
p
valu
differ
mrna
abund
identifi
use
student
ttest
compar
treat
mocktreat
cultur
three
independ
experi
sixteen
differ
mrna
abund
identifi
analyz
qrtpcr
fig
proteintr
pbmc
synthes
secret
significantli
p
inflammatori
cytokin
control
pbmc
cell
cultur
without
nm
protein
h
supernat
assay
cytokin
elisa
mean
se
three
independ
experi
shown
p
valu
determin
student
ttest
compar
proteintr
mocktreat
control
cultur
p
ns
summari
gene
identifi
analysi
treatment
protein
increas
abund
mrna
p
mrna
p
mrna
p
chemokin
chemo
attract
activ
monocyt
cytokin
mrna
activ
natur
killer
nk
cell
increas
p
interestingli
protein
treatment
increas
mrna
abund
p
mrna
p
gene
modul
viru
infect
cheung
et
al
tseng
et
al
mrna
abund
verifi
qrtpcr
show
transcript
accumul
increas
respons
protein
protein
treatment
also
increas
leptin
mrna
p
leptin
immunoregulatori
activ
receptor
mrna
increas
p
chemokin
receptor
increas
p
ltbr
receptor
tnf
increas
p
qrtpcr
ltbr
increas
cytokin
receptor
increas
p
p
respect
fold
increas
verifi
qrtpcr
howev
suggest
viral
protein
act
inflammatori
stimulu
pbmc
pbmc
treat
protein
show
increas
abund
mrna
p
ns
p
ns
p
ns
p
p
ns
product
secret
protect
cytokin
chemokin
treatment
pbmc
protein
analyz
addit
mrna
abund
studi
also
quantit
inflammatori
cytokin
chemokin
activ
elisa
assay
vitro
pbmc
treat
nm
protein
h
supernat
medium
cultur
test
cytokin
quantikin
elisa
assay
result
express
pgml
percentag
increas
secret
cytokin
proteintr
versu
mocktreat
compar
observ
treatment
protein
increas
level
secret
vitro
pbmc
fig
proteintr
cell
produc
significantli
p
p
p
p
increas
mrna
abund
signific
p
ns
result
show
increas
product
secret
protect
cytokin
chemokin
treatment
pbmc
protein
fig
product
secret
significantli
increas
pbmc
treatment
protein
kinet
dose
respons
effect
protein
vitro
pbmc
h
treatment
protein
nm
evalu
secret
express
pgml
mean
se
three
separ
experi
statist
signific
determin
use
student
ttest
base
comparison
proteintr
mocktreat
control
time
point
result
indic
protein
treatment
increas
product
dose
depend
manner
nm
gave
statist
signific
respons
compar
control
data
present
fig
show
effect
concentr
protein
synthesi
secret
chemokin
pbmc
cultur
supernat
measur
elisa
kinet
studi
perform
h
incub
treatment
nm
protein
show
dose
depend
increas
product
compar
control
cultur
time
period
pbmc
treat
protein
nm
produc
significantli
compar
control
correspond
p
h
p
h
p
h
lower
concentr
significantli
affect
product
nm
protein
increas
nm
protein
increas
h
respect
kinet
studi
perform
h
incub
show
signific
product
pbmc
protein
concentr
depend
manner
e
protein
similar
protein
envelop
protein
express
surfac
virion
infect
cell
compar
effect
e
protein
treatment
mrna
abund
pbmc
vitro
pbmc
treat
variou
concentr
e
protein
h
rna
extract
revers
transcrib
cdna
amplifi
qpcr
use
primer
specif
housekeep
gene
data
present
fig
show
rel
express
tai
valu
versu
e
treat
cultur
expect
protein
increas
mrna
abund
dose
depend
manner
follow
nm
nm
nm
nm
hand
treatment
e
protein
increas
mrna
abund
follow
nm
e
nm
e
nm
e
compar
control
result
indic
treatment
protein
increas
mrna
e
protein
increas
mrna
pbmc
synthesi
secret
proteinand
e
proteintr
pbmc
section
quantit
elisa
fig
protein
e
protein
treatment
increas
mrna
abund
product
secret
pbmc
vitro
pbmc
cell
treat
protein
nm
e
protein
nm
h
rna
extract
revers
transcrib
cdna
amplifi
gene
express
determin
realtim
quantit
pcr
rel
express
mrna
speci
calcul
use
compar
ct
method
statist
signific
determin
use
student
ttest
base
comparison
mocktreat
control
dose
signific
differ
mrna
abund
observ
pbmc
treat
protein
nm
compar
control
p
data
three
separ
experi
e
protein
increas
mrna
level
b
secret
concentr
h
follow
protein
e
protein
treatment
pbmc
determin
elisa
concentr
increas
proteintr
pbmc
proport
mrna
abund
wherea
secret
increas
e
proteintr
pbmc
compar
control
assay
supernat
medium
h
incub
pbmc
treat
protein
produc
dose
depend
manner
follow
pgml
increas
nm
pgml
increas
nm
pgml
increas
nm
pgml
increas
nm
compar
control
pgml
without
protein
pbmc
treat
e
protein
produc
less
follow
pgml
less
nm
e
pgml
less
nm
e
pgml
less
nm
e
compar
control
pgml
without
e
protein
fig
result
indic
protein
increas
secret
proport
increas
mrna
abund
e
protein
increas
secret
pbmc
next
determin
whether
product
depend
nfb
activ
proteolysi
order
inhibit
nfb
activ
examin
effect
pretreat
cell
tpck
nfb
inhibitor
inhibit
proteas
henkel
et
al
pbmc
cultur
cell
cultur
cell
pretreat
tpck
min
follow
protein
treatment
incub
presenc
tpck
h
treat
protein
alon
tpck
alon
mocktreat
serv
control
product
secret
supernat
medium
measur
elisa
result
show
pbmc
protein
alon
increas
significantli
pgml
versu
control
pgml
p
wherea
pretreat
pbmc
tpck
significantli
reduc
amount
produc
respons
protein
pgml
versu
protein
inhibitor
pgml
p
inhibit
mocktreat
pbmc
inhibitor
pgml
secret
produc
fig
similarli
cell
protein
alon
increas
significantli
pgml
versu
control
pgml
p
wherea
pretreat
tpck
significantli
reduc
amount
produc
respons
protein
pgml
versu
protein
inhibitor
pgml
mocktreat
cell
inhibitor
pgml
produc
fig
next
effect
tpck
inhibitor
secret
pbmc
measur
one
cycl
viru
replic
h
postinfect
tpck
partial
inhibit
secret
effect
seen
h
infect
suggest
postentri
event
involv
fig
tpck
toxic
virusinfect
cell
measur
plaqu
assay
yield
lower
pbmc
cultur
presenc
tpck
viru
titer
tpck
versu
pfuml
without
tpck
h
postinfect
result
indic
nfb
activ
requir
product
secret
respons
treatment
pbmc
cell
protein
howev
tpck
treatment
suffici
complet
inhibit
product
secret
pbmc
infect
moi
order
determin
effect
protein
treatment
nuclear
nfb
activ
measur
amount
activ
nfb
transcript
factor
nucleu
use
assay
measur
amount
nfb
bind
consensu
sequenc
immobil
well
plate
nuclear
fraction
pbmc
treat
protein
show
higher
level
nfb
dna
bind
activ
mocktreat
control
activ
level
pbmc
h
posttreat
protein
luminesc
unit
per
g
nuclear
protein
versu
control
increas
p
h
posttreat
protein
luminesc
unit
per
g
nuclear
protein
versu
control
increas
p
h
posttreat
protein
luminesc
unit
per
g
nuclear
protein
versu
control
increas
p
ns
fig
adher
cell
analyz
activ
level
fig
quantit
effect
protein
activ
nfb
nuclear
protein
extract
pbmc
cell
treat
protein
nm
mocktreat
control
assay
activ
nfb
g
nuclear
extract
ad
per
well
coat
nfb
consensu
dna
sequenc
amount
activ
nfb
bound
h
incub
measur
luminesc
unit
use
ez
detect
nfb
transcript
factor
assay
bar
repres
luminesc
activ
per
g
nuclear
extract
mean
se
three
independ
experi
result
show
pbmc
b
cell
treatment
protein
increas
nfb
activ
compar
control
cell
tpck
pretreat
reduc
nfb
bind
activ
respons
protein
p
h
posttreat
p
h
posttreat
protein
h
posttreat
protein
luminesc
unit
per
g
nuclear
protein
versu
control
increas
p
h
posttreat
protein
luminesc
unit
per
g
nuclear
protein
versu
control
increas
p
fig
cell
tpck
pretreat
reduc
nfb
promot
bind
activ
respons
protein
result
show
nfb
promot
activ
increas
pbmc
cell
treat
protein
tpck
pretreat
could
reduc
respons
next
examin
whether
tolllik
receptor
present
human
macrophag
could
interact
protein
induc
secret
use
cell
stabli
express
human
found
express
suffici
allow
product
respons
protein
pgml
versu
control
pgml
p
fig
cell
show
respons
protein
fig
import
observ
given
activ
sever
virus
viral
compon
predominantli
express
macrophag
human
finberg
et
al
cell
show
respons
protein
wherea
sar
pseudoviru
stimul
low
level
pgml
possibl
signal
fig
cell
psar
phiv
cotransfect
result
protein
synthesi
secret
sar
pseudoviru
supernant
medium
cotransfect
cell
examin
low
level
secret
pgml
found
fig
cotransfect
cell
protein
express
could
involv
stimul
product
cell
product
secret
detect
activ
fig
b
result
show
sar
protein
solubl
form
increas
product
ligand
interact
sarscov
respiratori
syndrom
numer
cytokin
chemokin
induc
attract
special
immun
cell
site
infect
et
al
adapt
immun
respons
initi
resolv
infect
cameron
et
al
elev
cytokin
immun
regulatori
gene
express
found
pbmc
patient
sar
yu
et
al
good
agreement
observ
show
mrna
abund
cytokin
elev
well
ligand
convalesc
elev
mrna
contribut
resolut
infect
neuroadapt
mous
hepat
viru
mhv
mous
brain
walsh
et
al
show
treatment
pbmc
protein
nm
lead
activ
indic
product
secret
sever
inflammatori
mediat
increas
secret
statist
signific
detect
elisa
assay
microaray
analysi
mrna
abund
also
increas
mrna
increas
appreci
studi
chemokin
induct
detail
pbmc
treat
protein
variou
concentr
product
secret
h
period
determin
elisa
level
increas
significantli
h
posttreat
protein
concentr
nm
compar
mocktreat
control
concentr
higher
level
bind
function
molecul
receptor
bind
specif
nm
affin
li
et
al
highli
potent
neutral
monoclon
antibodi
bound
inhibit
fusion
nm
sui
et
al
pbmc
carri
steadi
state
product
basal
level
mrna
sinc
also
involv
cellular
process
found
highli
variabl
basal
level
differ
individu
howev
protein
treatment
level
highli
elev
similarli
huang
et
al
found
acut
phase
sar
patient
sera
level
highli
variabl
significantli
differ
healthi
control
genet
studi
differenti
express
promot
variant
allel
show
signific
associ
p
cystic
fibrosi
lung
diseas
sever
hillian
et
al
result
show
protein
concentr
nm
significantli
increas
mrna
abund
pbmc
product
secret
could
enhanc
pbmc
one
mechan
includ
direct
activ
protein
indirect
prime
via
receptor
shown
increas
sar
patient
yu
et
al
secret
spike
could
produc
viru
infect
pulford
britton
show
recombin
e
protein
increas
mrna
abund
previous
versteeg
et
al
show
e
structur
protein
express
vaccinia
viru
l
cell
induc
mous
counterpart
sar
e
protein
interest
found
cell
surfac
late
infect
travers
lipid
bilay
ntermin
portion
protrud
detect
especif
antibodi
maeda
et
al
sinc
sar
syndrom
character
uncontrol
inflammatori
respons
nfb
major
transcript
factor
activ
acut
respiratori
distress
syndrom
ard
fan
et
al
sought
determin
whether
proteininduc
product
mediat
nfb
activ
examin
activ
nfb
inhibitor
tpck
nfb
inhibitor
act
inhibit
proteas
proteolyt
degrad
nfb
releas
undergo
nuclear
transloc
henkel
et
al
observ
addit
tpck
treatment
protein
significantli
inhibit
secret
suggest
nfb
activ
requir
proteininduc
secret
tpck
partial
inhibit
secret
pbmc
also
reduc
viru
yield
effect
pbmc
could
due
inhibit
proteas
possibl
induct
apoptosi
zhu
et
al
spike
resembl
sarscov
spike
sarscov
spike
contain
furin
recognit
site
uncleav
virion
cathepsin
l
cleavag
separ
receptorbind
subunit
membran
anchor
fusion
subunit
virus
use
clathrinmedi
endocytosi
human
aminopeptidas
n
receptor
mediat
entri
yeager
et
al
inou
et
al
inhibitor
cathepsin
l
cystein
proteas
block
cell
fusion
entri
via
endocytosi
virus
bosch
et
al
li
et
al
kawas
et
al
tpck
inhibitor
chymotrypsinlik
serin
proteas
prevent
mhv
spike
cleavag
cell
mizzen
et
al
class
inhibitor
block
sar
cleavag
spike
trimer
howev
factor
xa
membran
bound
proteas
could
cleav
sar
protein
function
subunit
benhcl
inhibitor
trypsin
serin
proteas
inhibit
cleavag
effect
block
viral
entri
du
et
al
thu
addit
nfb
inhibit
tpck
might
prevent
protein
cleavag
work
necessari
address
issu
verifi
nuclear
nfb
activ
increas
proteintr
pbmc
perform
direct
measur
activ
nfb
transcript
factor
bind
consensu
dna
sequenc
found
signific
increas
nuclear
nfb
transcript
factor
activ
proteintr
pbmc
cell
compar
mock
treatment
indic
protein
caus
specif
activ
nfb
signal
chang
et
al
suggest
receptor
posit
lung
epitheli
fibroblast
cell
sar
protein
induc
via
activ
signal
found
express
suffici
allow
product
respons
protein
like
tlr
activ
common
signal
pathway
culmin
activ
nfb
barton
medzhitov
predominantli
express
high
level
macrophag
human
activ
sever
virus
viral
compon
finberg
et
al
plasmacytoid
cell
use
tlr
pathway
viral
defens
barton
medzhitov
cell
use
cytosol
rna
receptor
helicas
rlh
uematsu
akria
nucleic
acid
recogn
tlr
critic
regul
product
type
ifn
respons
viru
infect
finberg
et
al
induc
barton
medzhitov
mrna
increas
proteintr
pbmc
experi
data
shown
mrna
shown
increas
pbmc
acut
phase
sar
patient
reghunathan
et
al
work
underway
confirm
observ
conclus
provid
evid
protein
induc
pbmc
vitro
cell
other
shown
lung
epitheli
cell
fibroblast
protein
induct
dose
depend
dose
nm
per
pbmc
increas
secret
significantli
compar
mocktreat
control
abil
protein
increas
mrna
mediat
activ
nfb
possibl
via
ligand
could
inhibit
nfb
inhibitor
tpck
abil
detect
elev
nfb
transcript
factor
activ
nucleu
respons
protein
suggest
like
occur
mechan
induct
moreov
increas
secret
cytokin
indic
level
proinflammatori
mediat
could
enhanc
protein
interact
monocyt
macrophag
could
stimul
nk
neutrophil
monocyt
migrat
site
infect
